AbTherx

🚀🚀 Learn about the new, updated industry standard for transgenic antibody discovery in this blog post titled "Next Generation Transgenic Mice for Antibody Discovery are here!" from our partners at The Jackson Laboratory. Read the blog post: https://lnkd.in/gF-AU9pp #transgenicmice #research #antibodydiscovery #antibodytherapeutics #innovation #atlasmice #abtherx #JAX

📣 Presentation recording now available! 📣 Learn more about Atlas™ Mice and our innovative binary fixed light chain and long CDR3 technologies.  Presented by Dan Rohrer, PhD, Chief Technology Officer at AbTherx during The Jackson Laboratory's recent virtual event. ▶️ Watch now: https://lnkd.in/duiXFsks #atlasmice #antibodydiscovery #abtherx #antibodytherapeutics #innovation

📣 We are thrilled to announce Jun Zhang has joined our team as Senior Scientist, Antibody Discovery. Jun has worked alongside many of our team members over the past 20 years at Medarex and Bristol Myers Squibb. Join us in welcoming Jun to the team! 👏 #drugdiscovery #abtherx #growingcompany

❄️ AbTherx Winter Shutdown Announcement ❄️ As the year draws to a close, our team is taking a well-deserved winter break to recharge and prepare for an exciting year ahead. Our offices will be closed from December 25 to January 2. During this time, our team will be offline, enjoying the holiday season with family and friends. We look forward to reconnecting with you in the new year, refreshed and ready to continue our journey together! #happyholidays #abtherx #wintershutdown #recharge #joy

Attending the Antibody Engineering & Therapeutics conference this week in San Diego? Join us for two amazing talks tomorrow, December 17, and learn how AbTherx and Parse Biosciences are working together to improve antibody discovery with best-in-class transgenic mice and single cell sorting technology!  👉 Dan Rohrer, PhD presents Atlas™ Mice Provide a New and Differentiated Toolset for Rapid Generation of Developable Human Therapeutic Antibodies  👉 Ajay Sapre presents Deep Mining of Antibody Repertoires with Single Cell B Cell Sequencing Tools from Parse Biosciences Can't make the AbTherx talk, but interested in the slides? Send us an email at info@abtherx.com. #AET2024 #AETsandiego2024 #atlasmice #antibodydiscovery #abtherx #antibodytherapeutics

Join us at the Antibody Engineering & Therapeutics 2024 conference to learn about our full human diversity, bispecific, and long CDR3 technologies, and explore how our customizable partnering models empower drug developers of all sizes. Our CTO Dan Rohrer, PhD will present the following: ⭐ SCIENTIFIC BRIEFING 4 - 📅 December 17 at 12:05 pm Atlas™ Mice Provide a New and Differentiated Toolset for Rapid Generation of Developable Human Therapeutic Antibodies ⭐ POSTER #4 - Advanced In Vivo Antibody Discovery Atlas™ Mice Provide a New and Differentiated Toolset for Rapid Generation of Developable Human Therapeutic Antibodies https://lnkd.in/g644RgAQ #AET2024 #AETsandiego2024 #atlasmice #antibodydiscovery #abtherx #antibodytherapeutics

We are excited to share the successful progression of our partnership with Parse Biosciences, resulting in the first-ever use of Evercode Mouse BCR for B cell analysis of transgenic mice. Read the press release and connect with us at the Antibody Engineering & Therapeutics (AET) conference in San Diego to learn why the highest-quality drug developers and technology innovators are partnering with AbTherx. https://lnkd.in/e_gPuzt4 #abtherx #transgenicmice #innovation #partnership

📣We are thrilled to announce Rafael Soares (Rafa) has joined our team as Senior Operations Manager. Rafa has worked alongside many of our team members over the past 20 years at Medarex, Bristol Myers Squibb, and Zai Lab. We look forward to achieving great things together! #drugdiscovery #abtherx #growingcompany

Having successfully developed multiple novel and innovative antibody discovery technologies under our original agreement with Gilead Sciences, we are excited to expand our partnership to include additional technologies and multiple new research programs. Read the press release: https://lnkd.in/exFsH-BQ #atlasmice #antibodydiscovery #abtherx #antibodytherapeutics #partnership

AbTherx is attending BIO-Europe! Connect with our Chief Executive Officer, Justin Mika, through the BIO partnering system to learn about our full human diversity, bispecific, and long CDR3 technologies, and explore how our customizable partnering models empower drug developers of all sizes. https://lnkd.in/dnuNZ2D #BIOEurope #BIOEurope2024 #atlasmice #antibodydiscovery #abtherx #antibodytherapeutics